Welcome! The Annual Sickle Cell Disease Therapeutics Conference (SCDTC) is a forum to discuss the latest advancements and future trends for treating patients with sickle cell disease.
The Annual Sickle Cell Disease Therapeutics Conference is a forum to discuss the latest advancements and future trends for treating patients with sickle cell disease. Conference attendees will hear presentations from healthcare companies, key opinion leaders, patients, policy makers and others.
Beverley Francis-Gibson, B.A., M.A.
President & Chief Executive Officer
Sickle Cell Disease Association of America, Inc.
PANELISTS AND SPEAKERS
Biree Andemariam, M.D.
Associate Professor, Department of Medicine
University of Connecticut
Dr. Lakiea Bailey, Ph.D.
Sickle Cell Community Consortium
Jeremie Estepp, M.D.
Medical Director, Clinical Translation Program in Hematology
St. Jude Children’s Research Hospital
Greg Kato, M.D.
Professor of Medicine, Director of the Adult Sickle Cell Center of Excellence for the UPP Division of Hematology-Oncology
University of Pittsburgh Medical Center